Identifying Predictors of Weight-Related Outcomes With Fixed-Dose, Extended-Release Naltrexone and Bupropion Among Treatment-Adherent Patients in Phase 3 COR Trials: A Treatment Target Analysis.
Saved in:
| Title: | Identifying Predictors of Weight-Related Outcomes With Fixed-Dose, Extended-Release Naltrexone and Bupropion Among Treatment-Adherent Patients in Phase 3 COR Trials: A Treatment Target Analysis. |
|---|---|
| Authors: | Ryan DH; Pennington Biomedical Research Center Baton Rouge Louisiana USA., Fitch A; knownwell Needham Massachusetts USA., Kushner RF; Northwestern University Feinberg School of Medicine Chicago Illinois USA., Tronieri JS; University of Pennsylvania Perelman School of Medicine Philadelphia Pennsylvania USA., Still CD; Geisinger Commonwealth School of Medicine Danville Pennsylvania USA., Apovian CM; Brigham and Women's Hospital Center for Weight Management and Wellness Boston Massachusetts USA. |
| Source: | Obesity science & practice [Obes Sci Pract] 2026 Jun 16; Vol. 12 (3), pp. e70159. Date of Electronic Publication: 2026 Jun 16 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: John Wiley & Sons Inc Country of Publication: United States NLM ID: 101675151 Publication Model: eCollection Cited Medium: Internet ISSN: 2055-2238 (Electronic) Linking ISSN: 20552238 NLM ISO Abbreviation: Obes Sci Pract Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2055-2238 |
|---|---|
| DOI: | 10.1002/osp4.70159 |
